GE Vernova Inc vs Twist Bioscience Corp — how do they compare? GE Vernova Inc trades at $1,026.03 (market cap $269.50B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: GE Vernova Inc is far larger — about 34.9× Twist Bioscience Corp's market cap, and GE Vernova Inc pays a 0.2% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| GEV | TWST | |
|---|---|---|
Market Cap | $269.50B | $7.72B |
Sector | Technology | Health |
52-Week High | $1.17K | $124.88 |
52-Week Low | $547.96 | $24.16 |
Enterprise Value | $259.17B | $7.65B |
Dividend Yield | 0.2% | — |
Trailing returns across standard periods
Latest headlines on both assets
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →